NexGel, Inc.

NXGL Healthcare Medical Instruments & Supplies

NexGel, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 31.5% from fiscal 2024.

Revenue
+27.8%
EPS
−344.4%
Free cash flow
−432.3%
Total debt
+353.8%

Quarter to June 2026, against a year earlier

3.60 0.52 −12.62%
Market cap
$12.7M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
5/9
Altman Z
−1.25
Beneish M
−3.41
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 4 5 5 2 3 5
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — 0.76 (0.12) (1.00) 1.27 (1.25)
P/S ratio
— 9.37 9.37 9.37 5.01 3.68 3.12 3.34 1.11
Altman Z″-Score (non-manufacturers)
— — (14.82) (13.13) 4.53 1.35 (4.38) (4.63) (6.91)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— — — — (46.34) (3.32) (0.77) (1.98) (3.41)
P/Operating CF
— (20.06) (20.06) (20.06) (6.50) (11.60) (21.74) (33.81) 45.00
P/B ratio
— 21.67 21.67 21.67 0.64 0.99 2.47 4.78 2.59
EV/Sales
— 8.49 8.49 8.49 (3.42) 0.58 2.59 3.25 1.09
EV/EBITDA
— 0.00 0.00 0.00 10.11 0.00 0.00 0.00 0.00
EV/FCF
— (3.76) (3.76) (3.76) 1.75 (0.40) (2.69) (6.55) (8.57)
Current Ratio
— 0.89 0.64 0.27 4.82 8.74 1.98 2.07 1.47
Net Debt/EBITDA
— 0.00 (0.35) (0.10) 24.97 3.32 0.67 0.32 0.13
Debt/Equity
— 0.00 2.41 3.61 0.02 0.04 0.10 0.15 0.15
ROE
— (571.26%) (581.85%) (1,003.99%) (70.91%) (48.13%) (49.32%) (58.35%) (54.69%)
ROA
— (510.96%) (146.29%) (109.19%) (44.80%) (34.72%) (31.09%) (31.34%) (27.98%)
ROIC
— 0.00% 0.00% (478.81%) 0.00% (161.46%) (72.95%) (42.98%) (45.90%)
Return on Tangible Assets
— (1,225.97%) (210.86%) 544.23% (36.64%) (64.42%) (78.89%) (67.58%) (89.90%)
Average Days of Receivables
— 5.61 51.92 39.53 49.18 39.57 56.50 39.20 21.51
Earnings Yield
— (53.77%) (53.77%) (53.77%) (55.41%) (62.96%) (24.89%) (11.21%) (23.60%)
Free Cash Flow Yield
— (24.11%) (24.11%) (24.11%) (38.85%) (39.41%) (30.81%) (14.84%) (11.45%)
Free Cash Flow per Share
— (0.31) (0.13) (18.75) (20.28) (11.08) (13.86) (13.24) (3.51)
Book value per Share
— 0.06 0.03 0.63 81.11 27.39 18.22 18.67 12.45
Free Cash Flow
— (1.54) (1.81) (2.11) (3.02) (3.09) (3.93) (4.31) (1.38)
EV/EBIT
— 0.00 0.00 0.00 2.06 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026